Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Monoclonal gammopathy of uncertain significance.
Alejo E, Puertas B, Mateos MV. Alejo E, et al. Among authors: puertas b. Med Clin (Barc). 2023 Sep 8;161(5):217-224. doi: 10.1016/j.medcli.2023.05.006. Epub 2023 Jun 15. Med Clin (Barc). 2023. PMID: 37330390 Review. English, Spanish.
Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients.
Puertas B, González-Calle V, Sureda A, Moreno MJ, Oriol A, González E, Rosiñol L, López J, Escalante F, Martínez-Lopez J, Carrillo E, Clavero E, Ríos-Tamayo R, Rey-Bua B, González-Rodríguez AP, Dourdil V, De Arriba F, González S, Pérez-de-Oteyza J, Hernández MT, García-Mateo A, Bargay J, Bladé J, Lahuerta JJ, San Miguel JF, Ocio EM, Mateos MV. Puertas B, et al. Haematologica. 2023 Oct 1;108(10):2753-2763. doi: 10.3324/haematol.2022.282490. Haematologica. 2023. PMID: 37102598 Free PMC article. Clinical Trial.
Multiple myeloma with t(11;14): impact of novel agents on outcome.
Puertas B, González-Calle V, Sobejano-Fuertes E, Escalante F, Rey-Bua B, Padilla I, García-Sanz R, Puig N, Gutiérrez NC, Mateos MV. Puertas B, et al. Blood Cancer J. 2023 Mar 20;13(1):40. doi: 10.1038/s41408-023-00807-9. Blood Cancer J. 2023. PMID: 36935422 Free PMC article.
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.
Puertas B, González-Calle V, Sobejano-Fuertes E, Escalante F, Queizán JA, Bárez A, Labrador J, Alonso-Alonso JM, García de Coca A, Cantalapiedra A, Villaescusa T, Aguilar-Franco C, Alejo-Alonso E, Rey-Bua B, López-Corral L, García-Sanz R, Puig N, Gutiérrez NC, Mateos MV. Puertas B, et al. Cancers (Basel). 2023 Mar 2;15(5):1558. doi: 10.3390/cancers15051558. Cancers (Basel). 2023. PMID: 36900349 Free PMC article.